BOCA RATON, Fla.–(BUSINESS WIRE)–VILAS Ventures, a healthcare-focused investment firm, announced its participation in the $13.5M Series A3 equity financing for CND Life Sciences, a pioneering diagnostics company developing innovative tools for the detection of neurodegenerative diseases….
Latest Series A3 financing includes Labcorp, along with new and longtime investors SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ — CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its…
According to filings with the U.S. Securities and Exchange Commission, CND Life Sciences is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Richard…
Phoenix, AZ – According to filings with the U.S. Securities and Exchange Commission, CND Life Sciences is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President, Richard Morello played a key…